GGrantIndex
← Leaderboards

Aron Lukacher

Emory University

$17,098,629
Attributed
$17,098,629
Total exposure
10
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,098,629 · 10

By mechanism

R01$12,317,693 · 6
R35$3,466,474 · 1
T32$787,302 · 1
R21$416,390 · 1
R29$110,770 · 1

Top collaborators

No co-investigators on record.

Most similar at Emory University

Same institution · by research overlap

Others in their field

Top investigators on “Polyomavirus

Research focus

PolyomavirusVirusPathogenInfectionT-LymphocyteFamilyMouse PolyomavirusPathogenesisCd8b1 GeneIn VivoCellsImmunityAntiviral AgentsCd4 Positive T LymphocytesMaintenanceMemoryBrainViralAcuteProgressive Multifocal LeukoencephalopathyInflammatoryAnimal ModelImmuneJc Virus

Grant awards (53)

Deciphering Early Stages of Polyomavirus CNS Pathogenesis and Immunity$896,585
R35 · FY2025 · NS · contact PI
Deciphering Early Stages of Polyomavirus CNS Pathogenesis and Immunity$70,902
R35 · FY2025 · NS · contact PI
Deciphering Early Stages of Polyomavirus CNS Pathogenesis and Immunity$869,688
R35 · FY2024 · NS · contact PI
Deciphering Early Stages of Polyomavirus CNS Pathogenesis and Immunity$70,699
R35 · FY2024 · NS · contact PI
Deciphering Early Stages of Polyomavirus CNS Pathogenesis and Immunity$896,585
R35 · FY2023 · NS · contact PI
Deciphering Early Stages of Polyomavirus CNS Pathogenesis and Immunity$71,341
R35 · FY2023 · NS · contact PI
Deciphering Early Stages of Polyomavirus CNS Pathogenesis and Immunity$590,674
R35 · FY2022 · NS · contact PI
Defining Early Stages of Polyomavirus CNS Pathogenesis and Immunity$430,944
R01 · FY2022 · NS · contact PI
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease$386,202
R01 · FY2021 · NS · contact PI
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease$386,301
R01 · FY2020 · NS · contact PI
Pathogenesis of Mouse Polyomavirus-associated CNS Demyelination$336,252
R01 · FY2020 · NS · contact PI
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease$383,993
R01 · FY2019 · NS · contact PI
Pathogenesis of Mouse Polyomavirus-associated CNS Demyelination$336,324
R01 · FY2019 · NS · contact PI
Pathogenesis of Mouse Polyomavirus-associated CNS Demyelination$336,395
R01 · FY2018 · NS · contact PI
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease$334,688
R01 · FY2018 · NS · contact PI
Pathogenesis of Mouse Polyomavirus-associated CNS Demyelination$336,463
R01 · FY2017 · NS · contact PI
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease$334,688
R01 · FY2017 · NS · contact PI
Pathogenesis of Mouse Polyomavirus-associated CNS Demyelination$336,529
R01 · FY2016 · NS · contact PI
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease$334,688
R01 · FY2016 · NS · contact PI
T-cell immunity to polyomavirus infection$382,500
R01 · FY2015 · AI · contact PI
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease$334,688
R01 · FY2015 · NS · contact PI
Viruses and Cancer$279,893
T32 · FY2015 · CA · contact PI
T-cell immunity to polyomavirus infection$382,500
R01 · FY2014 · AI · contact PI
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease$334,688
R01 · FY2014 · NS · contact PI
Viruses and Cancer$320,952
T32 · FY2014 · CA · contact PI
T-cell immunity to polyomavirus infection$359,550
R01 · FY2013 · AI · contact PI
Analysis of MHC Class Ib-Restricted Polyoma Virus-Specific CD8 T Cells$289,474
R01 · FY2013 · CA · contact PI
Viruses and Cancer$186,457
T32 · FY2013 · CA · contact PI
T-cell immunity to polyomavirus infection$382,500
R01 · FY2012 · AI · contact PI
Analysis of MHC Class Ib-Restricted Polyoma Virus-Specific CD8 T Cells$307,951
R01 · FY2012 · CA · contact PI
Analysis of MHC Class Ib-Restricted Polyoma Virus-Specific CD8 T Cells$311,976
R01 · FY2011 · CA · contact PI
T Cell Immunity to Polyoma Virus-Induced Tumors$225,372
R01 · FY2011 · CA · contact PI
T Cell Immunity to Polyoma Virus-Induced Tumors$58,463
R01 · FY2011 · CA · contact PI
Analysis of MHC Class Ib-Restricted Polyoma Virus-Specific CD8 T Cells$321,625
R01 · FY2010 · CA · contact PI
T Cell Immunity to Polyoma Virus-Induced Tumors$292,613
R01 · FY2010 · CA · contact PI
Analysis of MHC Class Ib-Restricted Polyoma Virus-Specific CD8 T Cells$321,625
R01 · FY2009 · CA · contact PI
T Cell Immunity to Polyoma Virus-Induced Tumors$292,613
R01 · FY2009 · CA · contact PI
T Cell Immunity to Polyoma Virus-Induced Tumors$292,613
R01 · FY2008 · CA · contact PI
Antiviral Therapy for Polyomavirus Infection$225,140
R21 · FY2008 · AI · contact PI
T Cell Immunity to Polyoma Virus-Induced Tumors$292,613
R01 · FY2007 · CA · contact PI
Regulation of Polyoma Virus-Specific CD8+ T Cells$256,540
R01 · FY2007 · CA · contact PI
Antiviral Therapy for Polyomavirus Infection$191,250
R21 · FY2007 · AI · contact PI
Regulation of Polyoma Virus-Specific CD8+ T Cells$264,202
R01 · FY2006 · CA · contact PI
T CELL IMMUNITY TO POLYOMA VIRUS INDUCED TUMORS$68,850
R01 · FY2006 · CA · contact PI
T CELL IMMUNITY TO POLYOMA VIRUS INDUCED TUMORS$283,860
R01 · FY2005 · CA
Regulation of Polyoma Virus-Specific CD8+ T Cells$270,560
R01 · FY2005 · CA
T CELL IMMUNITY TO POLYOMA VIRUS INDUCED TUMORS$283,860
R01 · FY2004 · CA
Regulation of Polyoma Virus-Specific CD8+ T Cells$270,560
R01 · FY2004 · CA
Regulation of Polyoma Virus-Specific CD8+ T Cells$292,810
R01 · FY2003 · CA
T CELL IMMUNITY TO POLYOMA VIRUS INDUCED TUMORS$283,860
R01 · FY2003 · CA
T CELL IMMUNITY TO POLYOMA VIRUS INDUCED TUMORS$280,839
R01 · FY2002 · CA
T CELL IMMUNITY TO POLYOMA VIRUS INDUCED TUMORS$304,921
R01 · FY2001 · CA
T CELL IMMUNITY TO POLYOMA VIRUS-INDUCED TUMORS$110,770
R29 · FY2000 · CA